imatinib mesylate has been researched along with Diaphragmatic Hernia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broomé, M; Frenckner, B; Lindström, M; Radell, P | 1 |
| Chang, YT; Eklöf, AC; Frenckner, B; Hedin, U; Lengquist, M; Osterholm, C; Ringman Uggla, A; Tran, PK; Tran-Lundmark, K | 1 |
2 other study(ies) available for imatinib mesylate and Diaphragmatic Hernia
| Article | Year |
|---|---|
Platelet-derived growth factor inhibition--a new treatment of pulmonary hypertension in congenital diaphragmatic hernia?
Topics: Benzamides; Bosentan; Combined Modality Therapy; Continuous Positive Airway Pressure; Diuretics; Enteral Nutrition; Extracorporeal Membrane Oxygenation; Heart Failure; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Humans; Hypertension, Pulmonary; Hypoxia; Iloprost; Imatinib Mesylate; Infant, Newborn; Male; Nitric Oxide; Piperazines; Protein Kinase Inhibitors; Purines; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sildenafil Citrate; Sulfonamides; Sulfones | 2008 |
Antenatal imatinib treatment reduces pulmonary vascular remodeling in a rat model of congenital diaphragmatic hernia.
Topics: Airway Remodeling; Animals; Apoptosis; Benzamides; Caspase 3; Cell Proliferation; Disease Models, Animal; Female; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Imatinib Mesylate; Ki-67 Antigen; Lung; Phenyl Ethers; Piperazines; Platelet-Derived Growth Factor; Pregnancy; Pulmonary Artery; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Platelet-Derived Growth Factor; RNA, Messenger | 2012 |